MedTrace Logo

Premium Monovision Versus Other Types of Monovision and Bilateral Trifocal Implantation.

NCT04618380 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2020-11-09

No results posted yet for this study

Summary

Primary objective of this study was to compare the efficacy of premium monovision with Restor and Panoptix, against other prevalent monovision techniques and against bilateral Panoptix implantation in a sample of patients following lens-extraction surgery.

Conditions

Interventions

DIAGNOSTIC_TEST

bUD-VA,bUN-RA, bUI-RA, bUI-CPS, bUN-CPS, contrast sensitivity

The following clinical indexes are evaluated: 1. Binocular uncorrected distant visual acuity (bUD-VA) using the Greek version of the Early Treatment Diabetic Retinopathy Study Chart at four meters distance 2. Binocular uncorrected reading acuity at 60cm (bUI-RA) and at 40cm (bUN-RA), and 3. Binocular uncorrected critical print size at 60cm (bUI-CPS) and at 40cm (bUN-CPS). All near and intermediate vision parameters are obtained using the Democritus Digital Acuity Reading Test (DDART), which is based on the Greek version of MNREAD. Contrast sensitivity are evaluated with the Pelli-Robson test.

Sponsors & Collaborators

  • Democritus University of Thrace

    lead OTHER

Principal Investigators

  • Georgios Labiris, MD,PHD · Department of Ophthalmology, University Hospital of Alexandroupolis, Alexandroupolis, Greece

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2020-07-31
Completion
2020-11-01

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04618380 on ClinicalTrials.gov